Main Conference: 28-30 April 2026 | Vienna, Austria
ATMP Development & Manufacturing
Lowering cell, gene and advanced therapy costs through automation and advanced analytics.
Go Beyond Theory on ATMP Commercialisation
The ATMP Development & Manufacturing track is a 3-day program focused on solving the biggest hurdles to commercialisation: such as the cost of goods and manufacturing complexities. This track provides actionable strategies from global leaders on how to automate manufacturing, enhance analytics, tackle CMC hurdles , and scale up the next generation of 'off-the-shelf' therapies
Track Themes: A Blueprint for Industrialising ATMPS
Solving the COGS Crisis
Hear real-world case studies on decreasing manufacturing costs and reducing plasmid dependency.
De-Risking the Journey to the Clinic
Master phase-appropriate CMC strategies and de-risk your tech transfer from the lab to GMP.
Automation & Allogeneic Frontiers
See how leaders are implementing closed, automated systems to scale 'off-the-shelf' allogeneic therapies.
The Future of Delivery
Go beyond viral vectors and explore the manufacturing and CMC challenges for in vivo and LNP-based delivery.
Meet the Advanced Therapy Experts
Get actionable strategies on ATMP analytics, tech transfer, and scaling from the pioneers turning advanced therapies into commercial realities.